NCT06987760 Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones
| NCT ID | NCT06987760 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ningbo No. 1 Hospital |
| Condition | Ureter Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 206 participants |
| Start Date | 2025-03-19 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 206 participants in total. It began in 2025-03-19 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparing the Efficiency, Effectiveness, and Safety of fURS lithotripsy with Similar RESDs in the Treatment of Upper Urinary Tract Stones.
Eligibility Criteria
Inclusion Criteria: \- 1.Patients with kidney stones or upper ureteral stones with a cumulative diameter of less than 3 cm are selected for ureteral soft lens holmium laser lithotripsy. 2.Age 18 to 80 years old, gender unlimited. 3.The subjects have no mental illness or language dysfunction, can understand the situation of the study and can sign informed consent. Exclusion Criteria: * 1.Patients with a history of ureteral stenosis or who have undergone open or laparoscopic ureteral or renal lithotomy. 2.Patients with fever one week before surgery 3.Pregnant women and menstruating patients. 4.Patients with combined systemic disease or inability to tolerate anesthesia. 5.Patients undergoing simultaneous surgery for bilateral upper urinary tract stones. 6.Patients with ureteral stent indwelling before surgery. 7.In patients with severe hydronephrosis, the separation of the renal collecting system is greater than 4 cm. 8.Patients with renal anatomic malformations such as polycystic kidney, horseshoe kidney, and ectopic kidney.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06987760 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Ureter Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06987760 currently recruiting?
Yes, NCT06987760 is actively recruiting participants. Contact the research team at fanyruo@126.com for enrollment information.
Where is the NCT06987760 trial being conducted?
This trial is being conducted at Ningbo, China.
Who is sponsoring the NCT06987760 clinical trial?
NCT06987760 is sponsored by Ningbo No. 1 Hospital. The trial plans to enroll 206 participants.